Citations 2
S201: CAMIDANLUMAB TESIRINE: UPDATED EFFICACY AND SAFETY IN AN OPEN-LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)
Ansell, S., Maddocks, Kami J. , Bence‐Bruckler, I., Kline, J., Mayer, Jiřı́ , Caimi, Paolo, Feldman, Tatyana , Hess, Brian , Eisen, S., Negievich, Yanina, Wang, L., Wuerthner, Jens, Herrera, Alex F. , Carlo‐Stella, Carmelo , Zinzani, Pier Luigi , Radford, John , Pinto, Antonio , Collins, Graham P. , Bachanová, Veronika , Bartlett, Nancy L. , Hamadani, Mehdi , Savage, Kerry J. , Advani, Ranjana H. , Casasnovas, Olivier , Bastos‐Oreiro, Mariana , Iyengar, Sunil
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 102-103
CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)
Herrera, Alex F. , Ansell, Stephen M. , Maddocks, Kami J. , Negievich, Yanina, Cruz, Hans G. , Wang, L., Wuerthner, Jens, Zinzani, Pier Luigi , Carlo‐Stella, Carmelo , Hamadani, Mehdi , Radford, John , Kline, Justin Paul , Savage, Kerry J. , Bartlett, Nancy L. , Caimi, Paolo F. , Collins, Graham P.
Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available